The Book of PeptidesThe Book of PeptidesPentadeca Arginate + TB-500
The post-2023 rebuild of the "Wolverine stack" (BPC-157 + TB-500) — the same tendon/ligament and post-injury use case, with Pentadeca Arginate standing in for BPC-157 after the FDA's "do not compound" action. The substitution is what's new here, not the stack — see the Wolverine record for the shared mechanism.
PDA is sold as the same 15-amino-acid repair peptide as BPC-157, carried as an arginine salt — so the mechanism story is the Wolverine record's, and all of it comes from animal and lab work, not human trials of either compound.
The published per-compound doses, timing, cycle length, the mechanism sources give for why it's combined, and the harm-reduction notes — the parts that took the most research to get right — are part of membership.